Crohn's disease (CD) is a complex genetic disorder for which a susceptibility gene, IBD1, has been mapped within the pericentromeric region of chromosome 16. In order to refine the location of IBD1, 77 multiplex CD families were genotyped for 26 microsatellite markers evenly spaced by approximately 1 cM. Nonparametric linkage analyses exhibited a maximum NPL score of 3.49 (P=2.37610 74 ) in a region centred by markers D16S3136, D16S3117 and D16S770. Simulation studies showed that the probability for IBD1 to be located in a 5 cM region around these markers was 70%. A 2.5 Mb YAC and BAC contig map spanning this genetic region on chromosome band 16q12 was built. TDT analyses demonstrated suggestive association between the 207 bp allele of D16S3136 (P50.05) and a new biallellic marker hb27g11f-end (P=0.01). These markers were located in the hb27g11 and hb87b10 BAC clones from the contig. Taken together, the present results provide a crucial preliminary step before an exhaustive linkage disequilibrium mapping of putatively transcribed regions to identify IBD1. European Journal of Human Genetics (2001) 9, 731 ± 742.
Introduction
Inflammatory Bowel Diseases (IBD), including Crohn's Disease (CD, MIM 266600) and Ulcerative Colitis (UC, MIM 191390) are common diseases occurring in young adults that are characterized by a chronic inflammation of the digestive tract. 1 Their combined prevalence has been estimated as high as 1 per 500 inhabitants in Western countries. 2 To date, the aetiology of IBD is unknown. 3 been investigated but to date, cigarette smoking is the only one confirmed to play a role in IBD. 5, 6 A genetic predisposition to IBD was initially suggested by ethnic and familial aggregations of the disease. 3 Twin studies further supported the hypothesis of a genetic component for IBD by demonstrating that the disease concordance rate was higher in monozygotic twins than in dizygotic twins. 7 ± 9 Finally, IBD susceptibility genes were recently mapped by linkage studies to chromosomes 1, 3, 5, 6, 7, 12, 14, 16, 19 and X. 10 ± 17 The first susceptibility locus for IBD (called IBD1) was localised to the pericentromeric region of chromosome 16. 10 Several independent studies have replicated this result. 18 ± 23 Recently, the analysis of 613 IBD families by an international genetic consortium confirmed these observations. 24 Although the IBD1 locus is involved in susceptibility to CD in homogeneous families, its role is still the subject of debate in UC and mixed families (ie families with members affected by either CD or UC).
In linkage studies the maximum value of the linkage statistic was uniformly located in a narrow genetic region centred on the microsatellite marker D16S411 (Table 1 ). In contrast, the confidence interval of this localization spans on a broad genetic region, estimated to be 20 ± 40 cM. This region is a priori expected to contain several hundred genes. Additional work is thus required to refine the location of the IBD1 locus and to identify the gene. In order to pursue this positional cloning strategy, new linkage analyses were performed on a family set using closely spaced microsatellite markers located in the pericentromeric region of chromosome 16 . A physical map of the region was also constructed. From this contig map,transmission disequilibrium tests allowed us to target the hb27g11 and hb87b10 BAC clones.
Subjects and methods
Subjects and ascertainment of phenotypic data Because IBD1 may have only a lesser role in UC and mixed families, families in which only CD was segregating were selected for this study. Seventy-seven multiplex CD families were recruited through a European consortium using previously published standardised diagnostic criteria based on clinical, radiological, endoscopic and histological findings. 25 Most of them (n=59, 77%) were recruited in the North of France and Belgium. Each European investigator obtained the approval of the relevant ethics committees to participate in the study and written informed consent was obtained from each participating family member. The 77 selected families contained at least two affected members. Altogether, the 77 families included a total of 261 healthy members and 179 CD patients accounting for 100 independent affected pairs. The affected family members were siblings (87 sibpairs), second-degree-relative (10 pairs), third-degree-relatives (two pairs) or half-sibs (one pair). In the subset of these 77 families, the proportions of patients with blood samples available for their two parents or only one parent were respectively 74% and 22%. For the remaining families, genotyping data from healthy sibs allowed the missing parental information to be inferred. Altogether, identity by descent information was available in nearly all studied families. For association studies, 31 additional simplex CD families were also included providing a total of 108 informative CD families.
Genotyping procedure of the microsatellite and biallelic markers Twenty-six microsatellite markers (summarized in Table 2 ) located in the vicinity of D16S411 were selected from public genetic databases (Ge Â ne Â thon: http://www.genethon.fr/, CHLC: http://www.chlc.org/, CEPH: http://www.cephb.fr/). Genomic DNAs were prepared from peripheral blood leukocytes 26 from the CD families and were genotyped using fluorescently labelled oligonucleotides, on an ABI 377 DNA Sequencer. Semi-automated fragment sizing was performed using the Genescan TM 2.1 software (ABI) followed by allele identification using the Genotyper TM 2.0 software (ABI).
Each genotype was determined independently by two investigators. Conflicting data were either resolved or discarded.
The biallelic marker (hb27g11-f) was also genotyped. Briefly, 100 ng of genomic DNA was amplified by PCR on Thermal Cycler (MJ Research, PTC-200) using 1 mM of forward and reverse primers (hb27g11f-forward: AGCAAATTCTAG-GAGTTATG, hb27g11f-reverse: TGATTTCGTAAGA- CAAGTG). A volume of 10 ml of the PCR products was then digested using 0.067 U/ml of Bsr1 enzyme (NEB). After digestion, the fragments were electrophoresed on a 2% agarose gel and the genotypes deduced from the migration profile.
Genotyping data analyses
Mendelian segregation of the alleles was checked using the Unknown program version 5.23. Marker ordering and intermarker distances were computed using the CRI-MAP program. 27 Any apparent double recombinants were identified and the corresponding families were genotyped again. The Kosambi map function was retained for map construction and the map computed by the CRI-MAP analysis was subsequently used for the linkage analyses. Nonparametric linkage analyses (NPL-score) were performed using the Genehunter computer program package version 2.0.
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The transmission disequilibrium test (TDT) and haplotype relative risk (HRR) were calculated using only one affected offspring per pedigree. 30, 31 In multiplex families, the proband was thus chosen at random. In order to limit sample biases, 100 random samples were generated and analysed independently. For each studied polymorphic marker, the median P-values of the statistic were recorded and this Pvalue was corrected for the number of tested alleles (ie alleles with an observed allele frequency higher than 0.01) using the Bonferroni correction.
Simulation studies
In order to calculate the confidence interval of the IBD1 localization by linkage analysis, simulation studies were carried out. Because no genetic model of inheritance was available, we used parameters compatible with the observed data (location and identity by descent vector at the maximum NPL-score) for simulation studies. For each microsatellite marker, genotypes were simulated for the set of 77 pedigrees using the observed allele frequency of the microsatellite markers to infer the genotypes of the founders. Non founder genotypes were then simulated according to Mendelian expectations. The affection status of each individual was determined stochastically according to the parameters of the genotype given above. One thousand simulations of the family data were carried out in this manner. For each simulation, the NPL-score was calculated as described in the genotyping data analysis section and the maximum of the score and its location were recorded.
Genomic library screening and contig construction Five Yeast Artificial Chromosomes (YAC), previously mapped to the pericentromeric region of chromosome 16 were used in order to anchor the contig of Bacterial Artificial Chromosomes (BAC) clones. YAC clone DNAs (825_A_8, 867_H_8, 868_C_11, 841_F_11 and 953_C_10) were prepared in agarose blocks, and further isolated and purified using the GENE- A contig of BAC clones containing Human genomic DNA fragments was built using the Human BAC library developed at the Jean Dausset-CEPH foundation. This library was derived from the human cell line 1347-02 cloned into vector pBeloBAC11. Two cloning sites, defined by the endonuclease restriction enzyme BamHI and HindIII, were used.
BAC clones mapping in the genetic region of interest were identified by an iterative PCR-based screening. At the starting point of the BAC contig construction, the BAC library was screened using the microsatellite markers cited in Table 3a . A search for STSs, genes and ESTs in published genetic maps, 32 provided 24 additional markers expected to map between D16S409 and D16S2623.
Positive BAC clones were then isolated and the ends directly sequenced using the fluorescent big dye terminator TM technology (Perkin Elmer, Applied Biosystems Division). These BAC end-sequences provided additional STSs, from which repeated elements were eliminated using the RepeatMasker program (http://repeatmasker.genome.washington. edu/RM) and used to screen again the CEPH-BAC libraries. This chromosome walking procedure was repeated until the BAC contig spanned the genetic region from D16S541 to D16S263 without any gaps. The results of the PCR experi- The inserts were then tested for their marker content by a PCR-based approach using the set of identified genetic markers (see above). PCR was performed in a final volume of 20 ml containing 300 pg of BAC DNA, and 20 pmol of each primer.
In order to confirm the robustness of the PCR-based strategy, the marker content of EcoRI restricted DNA from 43 BAC clones was also deduced by Southern blots using radioactive random labelled probes chosen from BAC-end sequences not containing repeats or published STS.
Fluorescence in situ hybridisation (FISH)
The chromosome preparation and FISH analysis were performed using classical methods with slight modifications. 33 A 250 ng biotinylated BAC DNA was mixed with 10 mg Cot-1 DNA and 50 mg of sonicated salmon sperm DNA in 10 ml of hybridisation buffer containing formamide (50%), and dextran sulphate (10%) in 26SSC. The mixture was denatured at 708C for 10 min and prehybridised for 1 h at 378C. Hybridisation was carried out overnight at 378C with normal human metaphase spreads on a microscope slide individually denatured for 2 min at 708C in 26SSC/70% formamide. Hybridisation was detected using avidin-FITC and the chromosomes were counterstained with DAPI. The metaphase images with G-bands were obtained with Vysis Quips System software related to a CCD camera.
Results

Genetic analyses
Linkage analyses were performed using a total of 77 multiplex CD families genotyped for 26 microsatellite markers. No UC or mixed families were included in our study. The genetic map generated by this genotyping data set spanned 38.4 cM. The first 25 microsatellite markers were mapped to a 25 cM region (Table 2) . Thus, the density of polymorphic markers was on average 1 per cM in the genetic region of interest. No major discrepancy between the genetic map drawn from this data set and the published maps was observed (data not shown). However, since the data from our families was more extensive than that previously published, we used the sexaveraged map estimated here in subsequent statistical analyses. Model-free linkage analyses confirmed that a susceptibility gene for IBD was located in the pericentromeric region of interest (maximum NPL score equal to 3.49, P=2.37610
74
). The maximum NPL-score was observed for a region containing the three microsatellite markers D16S3136, D16S3117 and D16S770 (Figure 1a) . The first one (D16S3136) was located 3.4 cM from D16S411. Outside of this region, the NPL score decreased dramatically and the genetic interval exhibiting a NPL score higher than 2.5 was less than 6.6 cM. As expected for a high density set of polymorphic markers, the information content was higher than 90% in this genetic region (Figure 1b) . At the maximum of the NPL-score, the identity by descent vector (z0, z1, z2) was equal to (0.19, 0.41, 0.4).
The genotyped family set was heterogeneous. It included 23 sibships that were used in our previous genome scan screening 10 and 54 newly recruited families. Out of these 77 families, six were included in the IBD International Genetics Consortium study. 24 Unfortunately, several of the families that we previously studied could not be genotyped since the corresponding DNA samples were no longer available. Because the family panel studied here was not independent of that used in our original study, the NPL-score was also computed for the 54 newly identified families only. The NPLscore curve showed a similar pattern to that observed for all the 77 families ( Figure 1c) . However, the maximum NPLscore was higher than for the total family set (NPL=4.67, P=1.6610
76
). Simulation studies were carried out under the hypothesis of a disease gene mapping between D16S3117 and D16S770 and exhibiting properties compatible with the observed identity by descent vector. For 1000 replicates the maximum NPL-score ranged from 0 to 7.17 (mean: 3.78; 95% CI: 1.58 ± 5.88). The location of the maximum NPL-scores varied over nearly the entire genetic region of interest from D16S3120 to D16S408. However, 28% of the positive replicates had the maximum NPL-score in the correct location and 70% of the maximum NPL-scores were located between D16S541 and D16S2623 ( Figure 2) .
Transmission Disequilibrium Test (TDT) 29 using only one affected member per family was performed for the 26 microsatellite markers. A weak association was observed for an allele of the markers D16S298 (P=0.02), D16S390 (P=0.05), D16S771 (P=0.03), D16S3080 (P=0.02) and D16S3136 (P=0.008). However, after applying the Bonferroni correction for the number of tested alleles, only a weak association between the 207 bp allele of the D16S3136 marker and the CD phenotype was remaining (P=0.05). The Haplotype Relative Risk (HRR) was also positive (P=0.006) for this allele.
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Since the initial association with D16S3136 was weak, we searched for a SNP in its vicinity. By direct sequencing of 12 unrelated individuals (10 CD patients and two unaffected individuals) we were able to locate a polymorphic sequence corresponding to the BAC end STS, hb27g11f. TDT analysis in CD families showed a significant association between the hb27g11-f marker and CD (P=0.01).
Altogether these results prompted us to further focus on the genetic region centred by D16S3117 and spanning the 4.6 cM from D16S541 to D16S2623. This region was considered small enough to justify construction of a high resolution physical map and linkage disequilibrium studies.
High-resolution physical map
We screened the CEPH-YAC and BAC libraries to identify clones in the region of interest. Initially, 5 YAC clones (825_A_8, 867_H_8, 868_C_11, 841_F_11 and 953_C_10) were identified using seven microsatellite markers (D16S3035 (m5), D16S3136 (m6), D16S541 (m7), D16S3117 (m8), D16S416 (m9), D16S770 (m10)), D16S2623 (m11). For six microsatellite markers (m5, m6, m7, m8, m9, m10) at least one clone was positive. The YAC clones were organized in a contig map of approximately 1.6 Mb (Figure 3) . Their respective sizes are indicated in the figure.
Since BAC clones have been reported to be more stable and to contain smaller insert sizes than YAC clones, we also screened the CEPH-BAC libraries. Using the same seven microsatellite markers, we identified 43 BAC clones, which were then used as starting points for chromosomal walks. The contig was further extended by 32 iterative screenings of the BAC libraries using 21 newly identified STS derived from BAC end-sequences (Table 3b and Figure 3 ) and 11 additional STS markers expected to be mapped to this region (Table 3a) .
This approach resulted in a BAC contig map that was 2.5 Mb wide, with a single gap between the m115 and m123 STSs (Figure 3) . Considering the sizes of the YAC clones, this gap was estimated to be less than 100 kb. The contig consisted of 99 BAC clones with an average insert size of 130 kb and an average redundancy of 5.3 BACs per genetic locus in this pericentromeric region of chromosome 16.
The contig provided a high-density STS map including 102 STSs (summarised in Table 3 ). The 99 BAC clones provided 79 new BAC end-related STSs (Table 3b ). Seven EST clusters (Unigene cluster: Hs.269950 (m134), Hs.40505 (m21), stSG32107 (m113), Hs.261614 (m119), Hs.92888 (m18), Hs.146128 (m19 and m24), Hs.26295 (m118)), and two known genes (ADCY7 (m192, m67, m193) and KIAA0849 (m13)), were also mapped on the contig (Figure 3) . On the other hand, one EST cluster (Hs.65885) and 15 known genes, Figure 1 Multipoint linkage analyses. The genetic distances shown on the X-axis were calculated by the Crimap program using the genotyping data of 77 CD families for 26 microsatellite markers. The Multipoint Nonparametric Linkage (NPL) scores and the information content were calculated using the GENEHUNTER PACKAGE version 2.0. Validation of the physical map and FISH mapping Southern-blot experiments using 59 STS-probes confirmed the efficiency of the PCR based screening approach for contig construction (data not shown). The only discrepancies observed after combining all PCR-STS data from the set of selected BAC clones were for clones hb233c8 and hb218c2. For these two clones, the suspicion of chimerism was confirmed by fluorescent in situ hybridisation experiments (data not shown). Four additional BAC clones (bb795b2, hb710c6, bb327a12 and bb1118e3) evenly spread across the contig were also analysed by FISH. They hybridised to the chromosome band 16q12 (Figure 4 ).
Discussion
The IBD1 gene, involved in the genetic predisposition to CD was previously mapped to the pericentromeric region on chromosome 16 . 10 This first localisation has now been confirmed by numerous independent groups and by a large international collaborative study (Table 1) . This study provides additional evidence that a CD susceptibility locus is located in this region. Indeed, model free linkage analyses, exhibited a very significant linkage (P=1.6610 76 ) in a newly recruited panel of 54 CD families. 34 Altogether, the results of the independent linkage studies, including this one, are highly concordant. This fact suggests that the effect of the IBD1 gene is detectable in most Caucasian populations and provides strong evidence that a susceptibility gene to IBD does reside in the pericentromeric region of chromosome 16. This conclusion is also supported by a large international consortium. 24 Several candidate genes for IBD1 have been mapped to this region. CD19, CD43, IL4R and CD11, which encode for lymphocyte receptors, appeared as good candidates for IBD1, considering their involvement in the immune response. However, previous association studies of these genes and the disease were negative (and unpublished data). 35 Consequently, we decided to pursue the positional cloning strategy towards the identification of the IBD1 gene. Because the involvement of the IBD1 gene in UC and mixed families is still controversial, this study was limited to CD only families. In order to avoid selection biases, we studied jointly the 54
% of Replicates Genetic markers Figure 2 Results of the simulation studies. A disease gene with two alleles (frequency of the disease allele = 0.06), with an incomplete penetrance and mapping between D16S3117 and D16S770 was hypothesised. One thousand replicates of the set of 77 CD families were carried out. For each replicate, the location of the maximum of the NPL score was recorded. The percentages of replicates exhibiting a maximum NPL score at each marker position is reported. Markers are ordered according to the genetic map (Table 2) . newly recruited families and the 23 available families recruited for the initial study. 10 The 1 cM spacing of the highly polymorphic markers used in this study provided a powerful tool for fine mapping of IBD1, as confirmed by the very high information content estimate. The maximum value of the nonparametric linkage statistic observed in these 77 CD families was located around the marker D16S3117. This marker is close (3.5 cM) to D16S411 which has often been reported as the most linked marker to IBD1 ( Table 1 ). Considering that previous studies were carried out using markers spaced about 10 cM apart, this difference was not unexpected. The plot of the NPL score exhibited a narrow peak suggesting that the confidence interval of the IBD1 location was small. Indeed, the 1-lod support interval covers a genetic distance of 6.6 cM. Simulation studies also argued for a small confidence interval showing that in 70% of cases, the maximum of the NPL-score was located in a 4.6 cM region around the gene. We judged that this interval was as small as could be expected using this approach and linkage studies were not pursued further.
Considering the uncertainty of the location that is typical of linkage studies when applied to complex genetic disorders, a larger linkage interval was expected. To explain this discrepancy, one can postulate that IBD1 may represent a strong risk factor for the disease. However, this hypothesis is not in accordance with the low calculated relative risk that can be attributed to the IBD1 locus (ls=1.3). A predominant effect of a small number of extended pedigrees linked to the disease could also be proposed, but detailed observation of the individual NPL-scores for the largest pedigrees failed to demonstrate a strong contribution of one or few families to the total NPL score (data not shown). The experimental observation thus remains to be explained.
In order to further characterise the genetic region, we constructed a BAC contig spanning from D16S541 to D16S2623. The reliability of the PCR based method for contig construction was confirmed by Southern blot experiments and the reliability of relative ordering of the BAC clones is supported by a non ambiguous integration in the contig of all the non chimeric clones. Only one small gap (less than 100 kb large) was unresolved in the present BAC contig. This lack of a corresponding clone in the CEPH BAC libraries may be the result of an unclonable sequence or a random under-representation of this sequence in the libraries. Further screening of other host-vector systems may help to resolve this point. The comparison between the genetic (4.6 cM) and physical (2.5 Mb) distances between the two more distant polymorphic markers suggests that this region has a high recombination rate (considering that the average recombination rate for the whole genome is estimated to be 1 cM for 1 Mb). FISH experiments using four independent BAC clones allowed us to map this contig to chromosome band 16q12.
The BAC contig was built using a PCR-based screening of the CEPH-BAC Human libraries. Thus, our data provide a practical evaluation of the quality of these libraries. In our experience, the average size of the clones is 130 kb with a redundancy higher than five genome equivalents. We observed a low rate of chimerical clones (2%) and a good coverage of the genetic region (only one gap 100 kb large in a 2.5 Mb contig). These results suggest that CEPH-BAC libraries are reliable tools for contig construction.
Cliff et al 36 have already constructed an initial probecontent BAC map of chromosome 16q providing 485% coverage of the long arm of this chromosome. Because these data were not available at the starting point of this study, we built the reported BAC contig for the purpose of IBD1 positional cloning. However, this new contig was built using a PCR based screening of independent libraries and thus provides new complementary data that may also contribute to reinforce the mapping projects of chromosome 16. 37, 38 In particular, it may help to identify the IBD1 locus and the Blau Syndrome gene. 39 In order to narrow the IBD1 localisation in this region, we looked for an association using the genotyped microsatellite markers. Because we looked for a linkage disequilibrium in the context of a known linkage, we used only unrelated CD patients (ie one trio per family) in the calculation. A weak positive association was observed for CD with the 207 bp allele of D16S3136 (P50.05). This microsatellite marker is located 0.1 cM apart from D16S3117, corresponding to the maximum of the linkage tests. Considering the number of tested markers (n=26) a false positive result was probable. We thus developed a new SNP (hg27g11-f) in its immediate Figure 4 FISH analysis of the BAC clone bb795b2. The hybridisation signal revealed by avidin-FITC confirmed the cytogenetic location of the clone on chromosome band 16q12.
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H Zouali et al 740 vicinity and we were able to confirm a weak linkage disequilibrium using this marker. Thus, altogether, linkage and linkage disequilibrium studies pointed out the same genetic region centered by D16S3136 and D16S3117 and the two overlapping BAC clones hb87b10 and hb27g11.
More recently, going on with the positional cloning approach of IBD1, we were able to confirm that the BAC clone hb87b10 contains not only several additional biallelic markers in linkage disequilibrium with CD but also the IBD1 gene. 40 
